DHR
DANAHER CORP /DE/
NYSE · Healthcare · Medical - Diagnostics & Research · US
$203.30
+1.58%Price chart
Aug 13Aug 18Aug 21Aug 26Aug 31Sep 3Sep 9Sep 14
Key dataSep 14, 2026
Open$202.48
From 52W high−16.01%
Volume3.42M
Market cap$142.92B
P/E (TTM)36.0x
P/S (TTM)5.7x
Div yield0.71%
Key dataSep 14, 2026
Open
$202.48
From 52W high
−16.01%
Volume
3.42M
Market cap
$142.92B
ValuationView details →
P/E (Fwd)
23.0x
EV/EBITDA
23.1x
P/E (TTM)
36.0x
RSI (14)
43.9
MomentumView details →
1D Return
+1.58%
YTD Return
−11.90%
SummaryUpdated Jun 1, 2026
Danaher Corporation (NYSE:DHR) is a diversified life sciences and diagnostics company founded in 1969 and headquartered in Washington, D.C. Originally established as Diversified Mortgage Investors, Inc., the company underwent a significant transformation and changed its name to Danaher Corporation in 1984. Over the decades, Danaher has evolved from a diversified industrial conglomerate into a focused life sciences powerhouse through strategic acquisitions and divestitures. The company went public in 1978 and has since built a portfolio of leading brands serving the biotechnology, life sciences research, and clinical diagnostics markets worldwide.
Similar companies
Latest newsMore news →
NANO Holdings announced that Jack Yamamori, with extensive M&A and management experience in the US, was appointed Vice Chairman in August 2026 to accelerate investment business growth.29d agoMasimo appointed Tim Benner as president, succeeding Katie Szyman who stepped down in June, following the company's acquisition by Danaher.36d ago